| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Surgery, Division of Urology, University of Massachusetts Medical School, Worcester, Massachusetts
Little is known about the roles of androgens in the regulation of redox state in the prostate, a cellular process believed to profoundly influence normal and aberrant prostate functions. We demonstrate that castration induced discrete oxidative stress (OS) in the acinar epithelium of rat ventral prostate (VP), as evident from marked increases in 8-hydroxy-2'-deoxy-guanosine and 4-hydroxynonenal protein adducts in the regressing epithelium. Testosterone replacement partially reduced OS in VP epithelia of castrates, but the level remained higher than in intact rats. Quantification of steady-state mRNA levels of 14 genes involved in the anabolism and catabolism of reactive oxygen species (ROS) showed that castration resulted in dramatic increases of three ROS-generating NAD(P)H oxidases (Noxs) including Nox1, gp91phox, and Nox4, significant reductions of key ROS-detoxifying enzymes (superoxide dismutase 2, glutathione peroxidase 1, thioredoxin, and peroxiredoxin 5), and unchanged levels of catalase, glutathione reductase,
-glutamyl transpeptidase, and glutathione synthetase. Testosterone replacement in castrated rats partially reduced expression of Noxs but restored expression of superoxide dismutase 2, glutathione peroxidase 1, thioredoxin, and peroxiredoxin 5 to complete normalcy and induced a compensatory increase in expression of catalase, glutathione reductase,
-glutamyl transpeptidase, and glutathione synthetase in the regenerating VP. Expression of superoxide dismutase 1, glutathione S-transferase-
, and glucose-6-phosphate dehydrogenase was unaffected by castration and testosterone replacement. These findings indicate androgen-deprivation induces OS in the rat VP through elevation of ROS anabolism and diminution of antioxidant detoxification. Androgen replacement partially reduces OS in rat VP to precastration levels. Expression of Noxs remained high amid a broad-based recovery of antioxidant defense mechanism(s). These data might have implications on the use of androgen blockade for prostate cancer prevention and androgen therapy for andropause treatment in elderly men.
This article has been cited by other articles:
![]() |
E. L. Kovacheva, A. P. Sinha Hikim, R. Shen, I. Sinha, and I. Sinha-Hikim Testosterone Supplementation Reverses Sarcopenia in Aging through Regulation of Myostatin, c-Jun NH2-Terminal Kinase, Notch, and Akt Signaling Pathways Endocrinology, February 1, 2010; 151(2): 628 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K Rao, Y. S Ziegler, I. X McLeod, J. R Yates, and A. M Nardulli Thioredoxin and thioredoxin reductase influence estrogen receptor {alpha}-mediated gene expression in human breast cancer cells J. Mol. Endocrinol., December 1, 2009; 43(6): 251 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeda, K.-i. Aihara, S. Yoshida, T. Sato, S. Yagi, T. Iwase, Y. Sumitomo, T. Ise, K. Ishikawa, H. Azuma, et al. Androgen-Androgen Receptor System Protects against Angiotensin II-Induced Vascular Remodeling Endocrinology, June 1, 2009; 150(6): 2857 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kumar, S. Koul, L. Khandrika, R. B. Meacham, and H. K. Koul Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype Cancer Res., March 15, 2008; 68(6): 1777 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Arnold, J. He, A. Remo, D. Ritsick, Q. Yin-Goen, J. D. Lambeth, M. W. Datta, A. N. Young, and J. A. Petros Nox1 Expression Determines Cellular Reactive Oxygen and Modulates c-fos-Induced Growth Factor, Interleukin-8, and Cav-1 Am. J. Pathol., December 1, 2007; 171(6): 2021 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N.C. Tam, I. Leav, and S.-M. Ho Sex Hormones Induce Direct Epithelial and Inflammation-Mediated Oxidative/Nitrosative Stress That Favors Prostatic Carcinogenesis in the Noble Rat Am. J. Pathol., October 1, 2007; 171(4): 1334 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, M. F. Leitzmann, N. Chatterjee, Y. Wang, D. Albanes, E. P. Gelmann, M. D. Friesen, E. Riboli, and R. B. Hayes Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 962 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alonso-Alvarez, S. Bertrand, B. Faivre, O. Chastel, and G. Sorci Testosterone and oxidative stress: the oxidation handicap hypothesis Proc R Soc B, March 22, 2007; 274(1611): 819 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Sullivan, J. M. Sasser, and J. S. Pollock Sexual dimorphism in oxidant status in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R764 - R768. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, C. B Foster, N. Chatterjee, A. Schatzkin, D. Reding, G. L Andriole, E D. Crawford, S. Sturup, S. J Chanock, and R. B Hayes Serum selenium and risk of prostate cancer--a nested case-control study Am. J. Clinical Nutrition, January 1, 2007; 85(1): 209 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cayatte, C. Pons, J.-M. Guigonis, J. Pizzol, L. Elies, P. Kennel, D. Rouquie, R. Bars, B. Rossi, and M. Samson Protein Profiling of Rat Ventral Prostate following Chronic Finasteride Administration: Identification and Localization of a Novel Putative Androgen-regulated Protein Mol. Cell. Proteomics, November 1, 2006; 5(11): 2031 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Morimoto, C A Mendoza-Rodriguez, M Hiriart, M E Larrieta, P Vital, and M A Cerbon Protective effect of testosterone on early apoptotic damage induced by streptozotocin in rat pancreas J. Endocrinol., November 1, 2005; 187(2): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Maranchie and Y. Zhan Nox4 Is Critical for Hypoxia-Inducible Factor 2-{alpha} Transcriptional Activity in von Hippel-Lindau-Deficient Renal Cell Carcinoma Cancer Res., October 15, 2005; 65(20): 9190 - 9193. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ouyang, T. L. DeWeese, W. G. Nelson, and C. Abate-Shen Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis Cancer Res., August 1, 2005; 65(15): 6773 - 6779. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |